These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2139541)

  • 1. Effects of indapamide on left ventricular mass and function in systemic hypertension with left ventricular hypertrophy.
    Komajda M; Klimczak K; Boutin B; Brackman F; Guez D; Grosgogeat Y
    Am J Cardiol; 1990 May; 65(17):37H-42H. PubMed ID: 2139541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of left ventricular hypertrophy in patients with essential hypertension. Results of 6 month treatment with indapamide.
    Curry CL; Robinson H; Brown R; Olivan J; Sami M; Honos G; Ruddy TD; Balazovjech I; Touzek F; Galinier F; Mariani M; de Cordoüe A; Barrandon S; Brault Y; Guez D
    Am J Hypertens; 1996 Aug; 9(8):828-32. PubMed ID: 8862231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of left ventricular hypertrophy in hypertension with indapamide.
    Sami M; Haichin R
    Am Heart J; 1991 Oct; 122(4 Pt 2):1215-8. PubMed ID: 1833967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of twelve-month combined therapy with perindopril and indapamide on the level of blood pressure and left ventricular hypertrophy in patients with hypertensive disease].
    Timofeeva LA; Alekhin MN; Ugriumov MO; Chumakova OS; Larina VN; Sidorenko BA
    Kardiologiia; 2006; 46(3):30-4. PubMed ID: 16710252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy and quality of life with indapamide alone or in combination with beta blockers or angiotensin-converting enzyme inhibitors.
    Athanassiadis DI; Dimopoulos CG; Tsakiris AK; Cokkinos DF; Tourkantonis AA; Toutouzas PK; Boutin B; Guez D
    Am J Cardiol; 1990 May; 65(17):62H-66H. PubMed ID: 2184654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of delapril in combination with indapamide on blood pressure and left ventricular mass in elderly hypertensive patients.
    Acanfora D; Lowenthal DT; Furgi G; Trojano L; Picone C; Nicolino A; Iannuzzi GL; Papa A; Rengo F
    Am J Ther; 1998 Jan; 5(1):17-23. PubMed ID: 10099033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study.
    Gosse P; Sheridan DJ; Zannad F; Dubourg O; Guéret P; Karpov Y; de Leeuw PW; Palma-Gamiz JL; Pessina A; Motz W; Degaute JP; Chastang C
    J Hypertens; 2000 Oct; 18(10):1465-75. PubMed ID: 11057435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indapamide regresses, but transdermal clonidine does not regress, left ventricular hypertrophy in hypertensive diabetic patients.
    Tan SA; Berk LS; Tan LG
    Am J Cardiol; 1996 Feb; 77(6):20B-22B. PubMed ID: 8848989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term effects of indapamide in left ventricular hypertrophy in patients with hypertension].
    Komajda M; Klimczak K; Evans J; Boutin B; Brackman F; Guez D; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():45-50. PubMed ID: 2150474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echocardiographic evaluation of left ventricular function in patients showing an antihypertensive and biochemical response to indapamide.
    Horgan JH; O'Donovan A; Teo KK
    Postgrad Med J; 1981; 57 Suppl 2():64-7. PubMed ID: 7033950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular hypertrophy in hypertensive patients in Indian primary care: prevalence and effect of treatment with sustained release indapamide.
    Lokhandwala Y; Damle A
    Curr Med Res Opin; 2004 May; 20(5):639-44. PubMed ID: 15140328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of indapamide on the quality of life of hypertensive patients.
    Guez D; Crocq L; Safavian A; Labardens P
    Am J Med; 1988 Jan; 84(1B):53-8. PubMed ID: 3341388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of indapamide on left ventricular hypertrophy in hypertension: a meta-analysis.
    Carey PA; Sheridan DJ; de Cordoue A; Guez D
    Am J Cardiol; 1996 Feb; 77(6):17b-19b. PubMed ID: 8848988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systemic hemodynamic evaluation of indapamide.
    Gensini G; Esente P; Giambartolomei A
    Clin Ther; 1983; 5(5):475-82. PubMed ID: 6616523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of left ventricular mass is accompanied by improvement in rapid left ventricular filling following antihypertensive therapy with metoprolol.
    White WB; Schulman P; Karimeddini MK; Smith VE
    Am Heart J; 1989 Jan; 117(1):145-50. PubMed ID: 2521417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of indapamide in elderly hypertensive patients with special emphasis on well-being.
    Werning C; Weitz T; Ludwig B
    Am J Med; 1988 Jan; 84(1B):104-8. PubMed ID: 3277414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study.
    de Luca N; Mallion JM; O'Rourke MF; O'Brien E; Rahn KH; Trimarco B; Romero R; De Leeuw PW; Hitzenberger G; Battegay E; Duprez D; Sever P; Safar ME
    Am J Hypertens; 2004 Aug; 17(8):660-7. PubMed ID: 15323062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regression of hypertensive heart hypertrophy caused by chronic angiotensin-converting enzyme inhibition].
    Motz W; Strauer BE
    Z Kardiol; 1988 Jan; 77(1):53-60. PubMed ID: 2834885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
    Rakić D; Rumboldt Z; Bagatin J; Polić S
    Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of indapamide sustained release 1.5 mg in hypertension.
    Donnelly R
    Clin Pharmacokinet; 1999; 37 Suppl 1():21-32. PubMed ID: 10491730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.